The beneficial effect of revascularization on jeopardized myocardium: Reverse remodeling and improved long-term prognosis

European Journal of Cardio-thoracic Surgery

Volumn 22, Issue 3, 2002, Pages 426-430

  Mule, Jacopo Dalle ^a   Bax, Jeroen J ^b   Zingone, Bartolo ^c   Martinelli, Felice ^d   Burelli, Claudio ^e   Stefania, Anna ^a   DiSipio, Liberata ^a   Soravia, Giorgio ^d  

^a Ospedale di Pieve di Cadore   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAGGIORE HOSPITAL   (Italy)

^d SAN MARTINO HOSPITAL   (Italy)

^e Azienda Ospedaliera   (Italy)

Author keywords

Heart failure; Nuclear imaging; Remodeling; Viable myocardium

Indexed keywords

AMIODARONE; ANGIOTENSIN ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; THALLIUM 201;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE CONTRACTION; HEART VENTRICLE REMODELING; HUMAN; IMAGING SYSTEM; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; STROKE VOLUME; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASCULAR PATENCY;

EID: 0036768518     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(02)00359-7     Document Type: Article

References (8)

1. Bonow R.O., Dilsizian V. Assessing viable myocardium with thallium-201. Am J Cardiol. 70:1992;10E-17E.
2. Beller G.A. Assessing prognosis by means of radionuclide perfusion imaging: what technique and which variables should be used? J Am Coll Cardiol. 31:1998;1286-1290.
3. Bonow R.O. Identification of viable myocardium. Circulation. 94:1996;2674-2680.
4. Rahimtoola S.H. Importance of diagnosing hibernating myocardium: how and in whom? J Am Coll Cardiol. 30:1997;1701-1706.
5. Dilsizian V., Smeltzer W.R., Freedman N.M.T., Dextras R., Bonow R.O. Thallium reinjection after stress-redistribution imaging: does 24-hour delayed imaging after reinjection enhance detection of viable myocardium? Circulation. 83:1991;1247-1255.
6. Bax J.J., Poldermans D., Elhendy A., Cornel J.H., Boersma E., Rambaldi R., Roelandt J.R., Fioretti P.M. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 34:1999;163-169.
7. Di Carli M., Davidson M., Little R., Khanna S., Mody F.V., Brunken R.C., Czernin J., Rokhsar S., Stevenson L.W., Laks H., Hawkins R., Schelbert H.R., Phelps M.E., Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 73:1994;527-533.
8. Vanoverschelde J.L., Depre C., Gerber B.L., Borgers M., Wijns W., Robert A., Dion R., Melin J.A. Time-course of functional recovery after coronary artery bypass graft in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol. 85:2000;1432-1439.